CMA
39
-4
WHR
57
-8
KHC
9
-6
EMC
48
-23
KR
45
-7
PHM
40
-8
NWL
50
-4
EXC
48
-3
MTCH
33
-7
MNST
44
-2
STZ
39
-5
PSA
38
-8
RCL
66
-10
STX
35
-7
ISRG
63
-8
UA
42
-5
ADBE
47
-3
ADP
55
-3
SJM
14
-7
RSG
54
-3
CMA
39
-4
WHR
57
-8
KHC
9
-6
EMC
48
-23
KR
45
-7
PHM
40
-8
NWL
50
-4
EXC
48
-3
MTCH
33
-7
MNST
44
-2
STZ
39
-5
PSA
38
-8
RCL
66
-10
STX
35
-7
ISRG
63
-8
UA
42
-5
ADBE
47
-3
ADP
55
-3
SJM
14
-7
RSG
54
-3
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
55

RYTM
Rhythm Pharmaceuticals

Last Price:
$55.48
Seasonality Move:
-8.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.4M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $68.1M
Return on Equity: 0%
Return on Assets: 0%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
55
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?